Zobrazeno 1 - 10 of 227 pro vyhledávání: '"P O, Bendahl"'
1
Noninvasive Staging of Lymph Node Status (NILS) in Breast Cancer using Machine Learning: External Validation and Further Model Development
Autor: M. Hjärtström, L. Dihge, P. O. Bendahl, I. Skarping, J. Ellbrant, M. Ohlsson, L. Rydén
BackgroundMost patients diagnosed with breast cancer present with node-negative disease. Sentinel lymph node biopsy (SLNB) is routinely used to stage the axilla, leaving patients with healthy axillary lymph nodes without therapeutic effects but at ri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0fe785e40e5a3b49894d940e4c05a6e9
https://doi.org/10.1101/2023.02.11.23285691
Zobrazit plný text záznamu
2
Akademický článek
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
Autor: E Gezelius, A Flou Kristensen, P O Bendahl, Y Hisada, S Risom Kristensen, L Ek, B Bergman, M Wallberg, U Falkmer, N Mackman, S Pedersen, M Belting
Publikováno v: PLoS ONE, Vol 13, Iss 11, p e0207387 (2018)
Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized anticoagulant treatment. The present sub-study of the RASTEN trial was designed to explore the
Externí odkaz: https://doaj.org/article/fc411eef701d46fe82a4b9ad222dfd3f
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Abstract P4-14-10: Withdrawn
Autor: Bo Nordenskjöld, Olle Stål, Maria Ekholm, Mårten Fernö, Lisa Rydén, P-O Bendahl
Publikováno v: Cancer Research. 79:P4-14
This abstract was withdrawn by the authors. Citation Format: Ekholm M, Bendahl P-O, Fernö M, Nordenskjöld B, Stål O, Rydén L. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Ph
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5fe0c0dfeb8d574cb862c2ff51ad98a2
https://doi.org/10.1158/1538-7445.sabcs18-p4-14-10
Zobrazit plný text záznamu
6
Abstract P3-13-03: Risk factors for reoperation following breast-conserving surgery integrated into pre- and postoperative models with high accuracy
Autor: Lisa Rydén, J Ellrant, E Plassgård, P-O Bendahl
Publikováno v: Cancer Research. 79:P3-13
Purpose: Breast-conserving surgery (BCS) is today applied in 60-70% of patients with invasive and in situ cancer and tumor size of 3 cm or less. However, a significant fraction of patients (10-40%) who undergo BCS require a reoperation due to incompl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0827dce4b7290752847218b6c054095b
https://doi.org/10.1158/1538-7445.sabcs18-p3-13-03
Zobrazit plný text záznamu
7
St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study
Autor: Looket Dihge, Ulrik Narbe, Lisa Rydén, Mårten Fernö, Christian Ingvar, P-O Bendahl
Publikováno v: The British journal of surgery. 108(12)
The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omission of completion axillary lymph node dissection (cALND), regardless of histological type, in patients with one or two sentinel lymph node (SLN) metastases. Concu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b745b7454b81564c84fb1bbfdcf77c
https://pubmed.ncbi.nlm.nih.gov/34636842
Zobrazit plný text záznamu
8
Abstract P3-08-13: Serum thymidine kinase activity is an independent prognostic factor for progression-free and overall survival in women with metastatic breast cancer
Autor: A-M Larsson, Kristina Aaltonen, Sara Jansson, Lisa Rydén, P-O Bendahl, Sharyn D. Baker, Michael Bergqvist
Publikováno v: Cancer Research. 78:P3-08
Introduction: Although prognosis and treatment of metastatic breast cancer (MBC) have improved over the last years, there is still an unmet clinical need for more precise prognostic and treatment monitoring tools. Liquid-based markers are preferred s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::899a8f941920864c3f83354fba4d1243
https://doi.org/10.1158/1538-7445.sabcs17-p3-08-13
Zobrazit plný text záznamu
9
Abstract P1-07-05: AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
Autor: Kristina Lövgren, Mårten Fernö, Martin Sjöström, Lisa Rydén, P-O Bendahl, Sara Alkner, Ulrik Narbe, Carina Forsare, Christian Ingvar, Flm Leeb-Lundberg
Publikováno v: Cancer Research. 78:P1-07
Background: Estrogen receptor (ER) positive HER2-negative breast cancer comprises 75–80% of all breast cancer. This fraction is even higher (>90%) in invasive lobular carcinoma (ILC). According to the St Gallen surrogate definitions of the intrinsi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b52e87d79f9c9cb5ca7cd2c69cbc46d3
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-05
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje